Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1998-03-23
2000-03-14
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 3166
Patent
active
060373377
ABSTRACT:
(R)-Ifosfamide is administered as a cytotoxic drug, in order to minimize side effects. (S)-Ifosfamide may be administered subsequently.
REFERENCES:
Kleinrok, Zdzislaw et al. (1986) "Pharmacological evaluation of ifosfamide and its enantiomers in laboratory animals," Arch. Immunol. Ther. Exp., vol. 34, pp. 293-304.
Kusniercyzk, H. et al. (1986) "Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates," J. Immunopharmacol., vol. 8, pp. 455-480.
Wainer, I.W. et al. (1994) "Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model," Cancer Res., vol. 54, pp. 4393-4397.
Masurel, Dominique et al. (1990) "Efficacy, toxicity, pharmacokinetics, and in vitro metabolism of the enantiomers of ifosfamide in mice," Cancer Res., vol. 50, pp. 252-255.
B. Testa et al. (1990) "Racemates Versus Enantiomers in Drug Development: Dogmatism or Pragmatism?" Chirality, vol. 2, pp. 129-133.
Blaschke, G. et al. (1986) "Preparative isolation and pharmacological-toxicological studies of the enantiomers of ifosfamide," Arzneim.-Forsch., vol. 36, pp. 1493-1495.
Baker Helen Frances
Batist Gerald
Ducharme Julie
Granvil Camille Pierre
Wainer Irving William
Darwin Discovery Limited
Goldberg Jerome D.
LandOfFree
Use of the enantiomers of ifosfamide in antitumor therapy for re does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of the enantiomers of ifosfamide in antitumor therapy for re, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the enantiomers of ifosfamide in antitumor therapy for re will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-169356